Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function

被引：0

作者：

S. L. Wong

S. Menacherry

D. Mulford

P. J. Schmitz

C. Locke

G. R. Granneman

机构：

[1] Department of Pharmacokinetics and Biopharmaceutics,

[2] D4PK,undefined

[3] AP 13A,undefined

[4] Abbott Laboratories,undefined

[5] 100 Abbott Park Road,undefined

[6] Abbott Park,undefined

[7] IL 60064-3500,undefined

[8] USA Tel. +1-847-938-0312; Fax +1-847-938-5193; e-mail shekman.wong@abbott.com,undefined

[9] Drug Analysis Department,undefined

[10] Abbott Laboratories,undefined

[11] USA,undefined

[12] Biotransformation Department,undefined

[13] Abbott Laboratories,undefined

[14] USA,undefined

[15] Psychopharmacology Venture,undefined

[16] Abbott Laboratories,undefined

[17] USA,undefined

[18] Biostatistics Department,undefined

[19] Abbott Laboratories,undefined

[20] USA,undefined

来源：

European Journal of Clinical Pharmacology | 1997年 / 52卷

关键词：

Key words Sertindole; Renal impairment; pharmacoki netics; hemodialysis; schizophrenia; antipsychotics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Objective: To study the effect of renal impairment on the pharmacokinetics of sertindole.

引用

页码：223 / 227

页数：4

共 42 条

[1] Pharmacokinetics of sertindole and dehydrosertindole in volunteers with normal or impaired renal function
Wong, SL
Menacherry, S
Mulford, D
Schmitz, PJ
Locke, C
Granneman, GR
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (03) : 223 - 227
[2] Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers
S. L. Wong
C. Locke
J. Staser
G. R. Granneman
Psychopharmacology, 1998, 135 : 236 - 241
[3] Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers
Wong, SL
Locke, C
Staser, J
Granneman, GR
PSYCHOPHARMACOLOGY, 1998, 135 (03) : 236 - 241
[4] Pharmacokinetics of vancomycin in patients with severely impaired renal function
GonzalezMartin, G
Acuna, V
Perez, C
Labarca, J
Guevara, A
Tagle, R
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1996, 34 (02) : 71 - 75
[5] Pharmacokinetics of Sertindole and its Metabolite Dehydrosertindole in Rats and Characterization of their Comparative Pharmacodynamics based on In Vivo D2 Receptor Occupancy and Behavioural Conditioned Avoidance Response
Bundgaard, Christoffer
Larsen, Frank
Kreilgaard, Mads
Brennum, Lise T.
Olsen, Christina Kurre
BIOPHARMACEUTICS & DRUG DISPOSITION, 2009, 30 (04) : 209 - 220
[6] Pharmacokinetics and Safety of Sunitinib Malate in Subjects With Impaired Renal Function
Khosravan, Reza
Toh, Melvin
Garrett, May
La Fargue, JoAnn
Ni, Grace
Marbury, Thomas C.
Swan, Suzanne K.
Lunde, Norman M.
Bello, Carlo L.
JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04) : 472 - 481
[7] Single-Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End-Stage Renal Disease Requiring Hemodialysis
Zomorodi, Katie
Chen, Dan
Lee, Lawrence
Lasseter, Kenneth
Marbury, Thomas
JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (08) : 1120 - 1129
[8] Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function
Renli Teng
Sharen Muldowney
Yonggang Zhao
Jolene Kay Berg
Jonathan Lu
Naeem D. Khan
European Journal of Clinical Pharmacology, 2018, 74 : 1141 - 1148
[9] Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function
Teng, Renli
Muldowney, Sharen
Zhao, Yonggang
Berg, Jolene Kay
Lu, Jonathan
Khan, Naeem D.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1141 - 1148
[10] A Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Lisdexamfetamine Dimesylate in Individuals With Normal and Impaired Renal Function
Ermer, James
Corcoran, Mary
Lasseter, Kenneth
Marbury, Thomas
Yan, Brian
Martin, Patrick T.
THERAPEUTIC DRUG MONITORING, 2016, 38 (04) : 546 - 555

← 1 2 3 4 5 →